“You don’t have to label to treat,” said Dr. Sharon Oberfield, a professor of pediatrics at Columbia University who co-authored a recent update on the diagnosis and treatment of PCOS in adolescents.
Columbia biomedical engineers have designed a bacteria strain that seeks out solid tumors and safely delivers immunotherapies, resulting in tumor regression in mouse models.
A new study shows how modifications to the tau protein may influence the different ways it can misfold in the brain, which is closely linked to the type of neurodegenerative disease that develops.
“It seemed like the relationship starts the moment you have imperfect hearing,” says Justin Golub, the study’s lead author and an ear, nose and throat doctor at Columbia University Medical Center.
A new Innovation Nucleation Fund from the Department of Pediatrics will provide seed funding to jumpstart six innovative research projects in children’s health.
Four research teams at Columbia University will share a $2.1 million grant to mount an aggressive effort to identify potential antiviral drugs and antibodies for use against the new coronavirus.
This July, Columbia neurologist Mitch Elkind will become president of the American Heart Association, only the second time a neurologist has led the organization.
Patients taking the recommended diuretic for hypertension experienced more potentially serious side effects than those taking a similar drug, according to a new study from Columbia researchers.
